Name: Arsenic Trioxide as Initial Therapy for Acute Promyelocytic Leukemia
Uploaded: 2011-09-14
Duration: 3 min
Description: Martin Tallman, a hematologist-oncologist at Memorial Sloan Kettering, discusses a clinical trial combining arsenic trioxide with all-tansretinoic acid (ATRA) for the treatment of patients with APL.

VIDEO | 3:00

Martin Tallman, Chief of the Leukemia Service at Memorial Sloan Kettering Cancer Center, discusses a new clinical trial combining arsenic trioxide with all-transretinoic acid (ATRA) for the treatment of patients with high-risk acute promyelocytic leukemia.